Megacal-M Injection

Land: Írland

Tungumál: enska

Heimild: HPRA (Health Products Regulatory Authority)

Virkt innihaldsefni:

Calcium borogluconate; Magnesium hypophosphite

Fáanlegur frá:

Ballinskelligs Vet. Products Ltd

ATC númer:

QA12A

INN (Alþjóðlegt nafn):

Calcium borogluconate; Magnesium hypophosphite

Skammtar:

4.6, 2.0, 0.8 percent weight/volume

Lyfjaform:

Solution for injection

Gerð lyfseðils:

LR: Licensed Retailer as defined in national legislation

Meðferðarhópur:

Cattle

Lækningarsvæði:

CALCIUM

Ábendingar:

Vitamins and minerals

Leyfisstaða:

Authorised

Leyfisdagur:

1991-10-01

Vara einkenni

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Megacal-M Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substances
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Solution for injection.
A clear, colourless to pale yellow sterile solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of the following conditions when complicated by
Phosphorus and Magnesium deficiency:-
Paresis caused by hypocalcemia before, during or after calving or
during lactation.
Downer cow syndrome (including during pregnancy) caused by deficiency
diseases or internal secretory dysfunction.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Calcium
4.6 % w/v
As Calcium Borogluconate
Phosphorous
2.0 % w/v
As magnesium hypophosphite
Magnesium
0.8 % w/v
As magnesium hypophosphite
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_1_
_/_
_0_
_8_
_/_
_2_
_0_
_1_
_2_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_2_
_9_
_8_
_3_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The solution should be warmed to body temperature before use.
Intravenous administration should be carried out slowly
and stopped at once if untoward symptoms occur.
As intravenous administration of this product could cause death, this
route should only be used by a veterin